The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis by Martínez Vizcaíno, Vicente et al.
RESEARCH ARTICLE
The Accuracy of Diagnostic Methods for
Diabetic Retinopathy: A Systematic Review
and Meta-Analysis
Vicente Martínez-Vizcaíno1,2*, Iván Cavero-Redondo1, Celia Álvarez-Bueno1,
Fernando Rodríguez-Artalejo3
1 Universidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain, 2 Universidad
Autónoma de Chile, Facultad de Ciencias de la Salud, Talca, Chile, 3 Universidad Autónoma de Madrid,




The objective of this study was to evaluate the accuracy of the recommended glycemic
measures for diagnosing diabetic retinopathy.
Methods
We systematically searched MEDLINE, EMBASE, the Cochrane Library, and the Web of
Science databases from inception to July 2015 for observational studies comparing the
diagnostic accuracy of glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), and 2-
hour plasma glucose (2h-PG). Random effects models for the diagnostic odds ratio (dOR)
value computed by Moses’ constant for a linear model and 95% CIs were used to calculate
the accuracy of the test. Hierarchical summary receiver operating characteristic curves
(HSROC) were used to summarize the overall test performance.
Results
Eleven published studies were included in the meta-analysis. The pooled dOR values for
the diagnosis of retinopathy were 16.32 (95% CI 13.86–19.22) for HbA1c and 4.87 (95% CI
4.39–5.40) for FPG. The area under the HSROC was 0.837 (95% CI 0.781–0.892) for
HbA1c and 0.735 (95% CI 0.657–0.813) for FPG. The 95% confidence region for the point
that summarizes the overall test performance of the included studies occurs where the cut-
offs ranged from 6.1% (43.2 mmol/mol) to 7.8% (61.7 mmol/mol) for HbA1c and from 7.8 to
9.3 mmol/L for FPG. In the four studies that provided information regarding 2h-PG, the
pooled accuracy estimates for HbA1c were similar to those of 2h-PG; the overall perfor-
mance for HbA1c was superior to that for FPG.
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Conclusions
The three recommended tests for the diagnosis of type 2 diabetes in nonpregnant adults
showed sufficient accuracy for their use in clinical settings, although the overall accuracy for
the diagnosis of retinopathy was similar for HbA1c and 2h-PG, which were both more accu-
rate than for FPG. Due to the variability and inconveniences of the glucose level-based
methods, HbA1c appears to be the most appropriate method for the diagnosis diabetic
retinopathy.
Introduction
In 1997, the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus stated
that the diagnosis of diabetes should focus simultaneously on plasma glucose concentrations
and its long-term microvascular complications, particularly diabetic retinopathy [1]. In 2009,
a report from the International Expert Committee (IEC) proposed glycated hemoglobin
(HbA1c) as an appropriate test for diagnosing diabetes [2]. The American Diabetes Federation
[3] and the World Health Organization [4] reinforced this recommendation and maintained
that both fasting plasma glucose (FPG) and 2-hour plasma glucose (2h-PG) after a 75-g oral
glucose tolerance test (OGTT) are appropriate tests for the diagnosis of diabetes in non-preg-
nant adults.
The variety of biomarkers for diagnosing diabetes poses a challenge for clinicians and health
planners [5]. Clinicians should consider the advantages and disadvantages of using the bio-
markers and decide which test, or which combination of tests in a pre-specified order, should
be used for each type of patient [6]. The advantages of HbA1c are it is not modified by acute
events, such as stress or vigorous physical exercise, and that it has greater pre-analytical stabil-
ity and renders more reliable results than glucose-based tests. However, it has also been
reported that HbA1c levels substantially depend on various non-glycemic factors, such as iron
or vitamin B12 deficiency, renal failure, or variables related to the lifespan of red blood cells
[7]. Moreover, neither the FPG nor the 2h-PG tests are influenced by individual susceptibility
to the glycation of hemoglobin, genetic factors and individual characteristics [8], such as age or
ethnicity. Furthermore, the costs of determining HbA1c are higher than those of FPG.
Diabetic retinopathy is an early diabetes-related complication that is a good criterion for
comparing the diagnostic accuracy of diabetes biomarkers [1]. The DETECT-2 project, an
international pool of nine studies from five countries, recently re-examined the relationship
between glycemic measures and retinopathy. It was suggested that the current diabetes diag-
nostic level for FPG could be lowered from 7.0 to 6.5 mmol/L and that an HbA1c level of 6.5%
(47.5 mmol/mol) is a suitable alternative diagnostic criterion [9]. The World Health Organiza-
tion, based on the level above which the risk of developing micro- and macrovascular compli-
cations increases, has also recommended the use of 6.1 mmol/L as FPG cutoff point for the
diagnosis of impaired fasting glucose; furthermore, the ADA recommended lowering this
threshold from 6.1mmol/l to 5.6mmol/l [3, 4]. However, to our knowledge, no previous study
has comprehensively reviewed and compared the accuracy of the main glycemic measures to
identify diabetes-specific retinopathy.
Thus, we conducted a systematic review and meta-analysis of the literature to evaluate the
accuracy of HbA1c, FPG and 2h-PG for diagnosing diabetic retinopathy.
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Methods
Literature search
A literature search was conducted in MEDLINE (via PubMed), EMBASE, the Cochrane Cen-
tral Register of Controlled Trials, the Cochrane Database of Systematic Reviews and the Web
of Science databases from their inception to July 17, 2015. Three comprehensive search themes
were combined using Boolean operators: [“HbA1c”OR “glycated hemoglobin” OR “glycated
hemoglobin” OR “hemoglobin A1c” OR “glucose”OR “fasting glucose”] AND [“threshold”
OR “cut-off” OR “cut point”OR “sensitivity” OR “specificity”OR “diagnostic” OR “differential
diagnosis”] AND [“microvascular complications” OR “retinopathy” OR “retinal”]. The refer-
ence lists of the retrieved articles were reviewed for additional studies. The literature search was
performed independently by two reviewers (IC and CA), and inconsistencies were resolved via
conference.
Selection criteria
We aimed to identify original articles analyzing the HbA1c, FPG and 2h-PG thresholds associ-
ated with an increased frequency of retinopathy. The following inclusion criteria were used: i)
study participants were individuals aged18 years; ii) index tests used were HbA1c, FPG and
2h-PG; iii) an outcome of diabetic retinopathy at any stage; and iv) study designs including
cross-sectional, case-control, or cohort studies, with either prospective or retrospective data
collection. The exclusion criteria were as follows: i) insufficient data to calculate sensitivity or
specificity; ii) studies conducted only with diagnosed diabetic individuals; iii) studies con-
ducted on gestational diabetes; and iv) studies written in a language other than English or
Spanish. When multiple articles reported data from the same study, the most recent article was
selected.
Data extraction and quality assessment
The following data were collected from each study were included in this review: 1) author iden-
tification, 2) year of publication, 3) country of the study, 4) year of data collection, 5) ophthal-
mic examination test, 6) age of the participants, 7) number of participants, 8) prevalence of
retinopathy and 9) parameters summarizing the accuracy of the test (cut-off, sensitivity, speci-
ficity, area under curve (AUC) and the diagnostic odds ratio (dOR)).
We used the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool to
evaluate four domains of each study: patient selection, index test, reference standard and flow
of patients and timing of the tests. Each domain was evaluated in terms of the risk of bias, and
the first 3 domains were also evaluated in terms of concerns regarding the applicability of the
results [10].
Data extraction and quality assessment were independently performed by IC and CA, and
inconsistencies were managed by consensus.
Statistical analysis and data synthesis
This study was reported according to the PRISMA [11] statement (Table A and Figure A in S1
File) and the recommendations of the Cochrane Collaboration Handbook [12]. The sensitivity,
specificity, AUC and dOR as well as their corresponding 95% confidence intervals (CIs) were
calculated for HbA1c, FPG and 2h-PG in each included study. Although the protocol of this
meta-analysis specified that at least five studies were required in a subgroup to conduct the
pooled estimations, a meta-analysis including only four studies is provided at (Table B in S1
File).
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Hierarchical summary receiver operating characteristic curves (HSROC) were used to sum-
marize the overall test performance. The HSROC have been proposed to estimate the perfor-
mance of diagnostic tests on data from a meta-analysis, and the AUC is not only useful to
evaluate not only the curve but also the strength of the heterogeneity [13]. To reach a threshold
of excellent accuracy, the AUC must be in the region of 0.97 or higher. An AUC of 0.93 to 0.96
is very good and an AUC of 0.75 to 0.92 is good. An AUC less than 0.75 may be reasonable, but
the test has evident shortcomings in its diagnostic accuracy [14]. When a study did not provide
information about the AUC, it was calculated.
The dOR was computed using Moses’ constant of a linear model, which indicates that this
approach relies on the linear regression of the logarithm of the dOR of a study (dependent vari-
able) and on an expression of the positivity threshold of that study (independent variable). The
dOR is a measure of the accuracy of the test data that combines sensitivity and specificity into a
single value. The dOR values range from 0 to infinity, with higher values indicating a better dis-
criminatory test performance (higher accuracy). A dOR of 1.0 indicates that a test does not dis-
criminate between patients with the disorder and those without it [15].
Forest plots were used to display the sensitivity, specificity, AUC and dOR for each glycemic
parameter in the reviewed studies. The heterogeneity of the results across studies was evaluated
using the I2 statistical parameter. I2 values of<25%, 25–50% and>50% usually correspond to
small, medium and large heterogeneity, respectively [16]. Given that in most cases the hetero-
geneity was large, the results of the different studies were pooled using a random-effects model
with the Der Simonian and Laird method.
The separate influence of each study in the pooled dOR was estimated by recalculating the
pooled estimate after the exclusion of individual studies. Finally, publication bias was visually
evaluated using a funnel plot, as well as with the method proposed by Deeks [17].
Statistical analyses were performed using StataSE software, version 13 (StataCorp).
Results
Baseline Characteristics
A total of 2,632 articles were retrieved from the literature search. After removing 552 dupli-
cated articles, the titles and abstracts of 2,080 studies were screened. We excluded 2,028 studies
that clearly did not fulfil all of the inclusion criteria or met at least one of the exclusion criteria,
leaving 52 studies that were reviewed in full. Next, 41 of the studies were excluded following
the full text reading (see study exclusion in References A in S1 File), and the remaining 11 arti-
cles were used for the final analysis (Fig 1) [18–28].
The 11 studies comprising this review included 45,686 participants. The studies were con-
ducted in China, North America, Japan, Korea, India, Malaysia, France and Australia; one
study was conducted among Pima Indians. The age of the participants ranged from 18 to 79
years. The retinopathy prevalence varied from 1.6% to 15.8% across the studies. All of the stud-
ies provided information on the global diabetic retinopathy prevalence, except one study that
reported only moderate non-proliferative retinopathy [19]. All of the studies except for one,
which also showed prospective data [28], had cross-sectional designs. Only four studies pro-
vided information regarding 2h-PG [19, 22, 27, 28]. Finally, one study provided several cut-
offs for FPG; however, we selected the internationally recommended cut-off of 7.0 mmol/L for
this analysis (Table 1).
Study Quality
As evaluated with QUADAS-2, all of the studies included information regarding the seven
quality items. However, the studies had shortcomings in two domains: the index test and the
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reasons for excluding participants. In fact, most studies interpreted their results without refer-
ence to a standard (HbA1c: 78%; FPG: 60%; and 2h-PG: 75%) and only considered the pre-
specified index test threshold (Table C and Figure A in S1 File).
Meta-analysis
Fig 2 depicts the dOR funnel plots of HbA1c and FPG. There was substantial heterogeneity
across the studies in the dOR of retinopathy based on HbA1c (I2 = 92.7%) and FPG (I2 =
95.1%). The pooled dOR for the diagnosis of diabetic retinopathy was 16.32 (95% CI, 13.86–
19.22; p< 0.001) for HbA1c and 4.87 (95% CI, 4.39–5.40; p< 0.001) for FPG. The pooled
Fig 1. Literature search PRISMA consort diagram.
doi:10.1371/journal.pone.0154411.g001
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Fig 2. Forest plot of the diagnostic odds ratio (dOR) of each index test in the reviewed studies.CI: confidence interval; (a), (b) and (c)
indicate different subgroups of participants in that study, as defined by setting (Table 1).
doi:10.1371/journal.pone.0154411.g002
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sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), dOR
and AUC for HbA1c and FPG are shown in Table 2 (Figure B, C, D and E in S1 File depict sen-
sitivity, specificity, PLR and NLR funnel plots, respectively)
The area under the HSROC (Fig 3) estimating the discriminating accuracy of HbA1c for
identifying retinopathy was 0.837 (95% CI: 0.781–0.892; p< 0.001) and was 0.735 (95% CI:
0.657–0.813; p< 0.001) for FPG. The 95% confidence region for the point that summarized
the overall test performance included studies in which the test cut-offs ranged from 6.1% (43.2
mmol/mol) to 7.8% (61.7 mmol/mol) for HbA1c and from 7.8 to 9.3 mmol/L for FPG.
When we estimated the pooled accuracy parameters from the four studies that evaluated the
diagnostic performance of HbA1c, FPG and 2h-PG in the same sample, the pooled dOR was
34.68 (95% CI, 23.56–51.03; p< 0.001) for HbA1c, 24.79 (95% CI, 17.40–35.32; p< 0.001) for
FPG and 32.39 (95% CI, 25.27–41.51; p< 0.001) for 2h-PG. In addition, the pooled AUC was
0.882 (95% CI: 0.835–0.930; p< 0.001) for HbA1c, 0.868 (95% CI: 0.824–0.912; p< 0.001) for
FPG and 0.916 (95% CI: 0.870–0.963; p< 0.001) for 2h-PG (Table C in S1 File).
Sensitivity analysis for the effect of individual studies
When the impact of individual studies was examined by removing studies from the analysis
one at a time we observed that the pooled dOR estimation for HbA1c increases after removing
data from the Cheng et al. [25] study (dOR, 21.26 [95% CI: 17.86–25.31]). The pooled dOR for
FPG also increases after removing data from the Wong et al. [26] study (dOR, 5.4 [95% CI:
5.14–6.64]), but decreases after removing data from the Park et al. [27] study (dOR, 4.37 [95%
CI: 3.93–4.86]) (Figure F in S1 File).
Publication bias
The asymmetry test, using Deek’s method [17], did not suggest the existence of publication
bias either for HbA1c (intercept, 2.85 [95% CI: −0.65–5.76]; p = 0.054) or for FPG (intercept,
0.67 [95% CI: −0.29–1.63]; p = 0.151) (Figure G in S1 File).
Discussion
The most recent recommendations propose HbA1c as a good test for diagnosing diabetes in
non-pregnant adults and also include FPG and 2h-PG as appropriate methods [3, 4]. Thus,
which of the recommended tests should be used remains controversial. In our meta-analysis of
11 studies, HbA1c performed better than FPG in identifying individuals with diabetic retinopa-
thy. Moreover, our data indicate that the three glycemic tests have sufficient diagnostic
Table 2. Pooled accuracy parameters in the diagnosis of diabetic retinopathy, by index test. Values in
parentheses are 95 per cent confidence intervals. FPG: fasting plasma glucose, PLR: positive likelihood
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Fig 3. Hierarchical summary receiver operating characteristic (HSROC) curves summarizing the
ability of glycated haemoglobin (HbA1c) and fasting plasma glucose (FPG) to identify diabetes
retinopathy.
doi:10.1371/journal.pone.0154411.g003
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accuracy on diabetic retinopathy in clinical practice, supporting the current international
recommendations.
Our meta-analysis of the four studies [19, 22, 27, 28] that compared these three tests in the
same set of patients showed that, overall, 2h-PG and HbA1c have similar accuracy estimates
for diabetes retinopathy in terms of the dOR and AUC and are better than FPG. In recent
decades, the 2h-PG after a 75-g oral glucose tolerance test (OGTT) has been the preferred test
for confirming a diagnosis of diabetes in clinical practice, but because it is time-consuming and
labor-intensive [29], both the FPG and HbA1c tests are considered good alternatives [2, 4].
Although the pooled specificity in the meta-analysis of the 11 studies comparing HbA1c
and FPG was similar, the pooled sensitivity for HbA1c was 2-fold higher than that for FPG,
and the pooled dOR was almost 4-fold higher. Regarding the low sensitivity of FPG, the Diabe-
tes Prevention Program [30] and NHANES [25] reported that 8% of individuals with a FPG
below diabetic thresholds had retinopathy. Thus, using the recommended FPG cut-off of 7.0
mmol/L for the diagnosis of diabetes [2, 3, 4], a not negligible percentage of cases of diabetic
retinopathy would be undiagnosed. Other advantages of HbA1c are that it can be measured in
a non-fasting state and it has good pre-analytical stability and low day-to-day variability. How-
ever, HbA1c has some limitations: diabetes is defined by high blood glucose rather than by gly-
cation of proteins and HbA1c does not reflect postprandial glycaemia [5].
Authors have questioned the use of diabetes retinopathy as the gold standard for the diagno-
sis of diabetes because no uniform glycemic threshold for the presence of retinopathy has been
found across populations [26]. Moreover, most studies relating HbA1c to retinopathy have
been cross-sectional and have not excluded individuals with diagnosed diabetes (even if treated
with hypoglycemic drugs, and the reported thresholds were dependent on the statistical meth-
ods used, the definition of retinopathy, and factors influencing HbA1c levels, such as individual
susceptibility to glycation and aging. However, currently, no other clinical diagnostic standard
exists for diabetes.
Meta-analyses of diagnostic tests synthetize the performance of a test providing a pooled
estimation of diagnostic accuracy parameters, and also estimates a summary point (a summary
sensitivity and specificity estimates) and a HSROC, but not allows the identification of the opti-
mal cut-off point [31]. However, the cut-offs within the 95% confidence region for HbA1c ran-
ged from 6.1% (43.2 mmol/mol) to 7.8% (61.7 mmol/mol) and from 7.8 to 9.3 mmol/L for
FPG. These findings support the cut-offs proposed by the International Expert Committee for
the diagnosis of diabetes using HbA1C, but not for FPG [2].
As is common in diagnostic meta-analyses, all of the estimations of the diagnostic accuracy
were performed considering the large variability across individual studies. A substantial part of
this variability is derived from a threshold effect due to the differences in the thresholds used to
determine positivity in the tests. Factors influencing the threshold effect across the studies
include the criteria for the diagnosis of retinopathy, the statistical methods used for defining
cut-offs, and the assay methods used to measure diagnostic tests, particularly HbA1c. The wide
clinical spectrum of patients included in the studies is also responsible for a substantial propor-
tion of variability across the studies. While participants in some studies are a representative
sample of the general population, other studies included selected samples with a known high
prevalence of diabetes. Moreover, some studies removed individuals undergoing antidiabetic
drug treatment from the analyses, and others accounted for potential modifiers, such as age or
hypertension. In fact, the threshold effect and the wide spectrum of patients could explain the
“shoulder arm” found in the HSROC graphics, which partially results from the inverse correla-
tion between the sensitivity and specificity. Note that this correlation and the large variability
in diagnostic accuracy across the studies support the use of HSROC because they explicitly
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addresses the relationship between sensitivity and specificity using the threshold [32] and
account for inter-study heterogeneity.
In the sensitivity analysis we observed that the estimate of the pooled dOR decreases after
removing Park et al study [20], because it involved a large and homogenous sample, and conse-
quently higher estimates of sensitivity and specificity. After removing two other studies, the
estimate of the pooled dOR increases owing to: the Cheng et al study [25] included mostly pop-
ulation at high risk for developing diabetes and considered a cut-off for diagnosing of retinopa-
thy of 5.5% for HbA1c, and therefore provides high sensitivity and low specificity estimates;
the Wong et al. study [26] reported low sensitivity estimates including three population-based
samples, and excluded participants who had ungradable retinal photographs. A review that
analyzed the potential sources of bias and variation in diagnostic accuracy studies, suggested
that high variability in the characteristics of participants in the studies testing the accuracy of
tests for diabetes retinopathy is significantly associated to lower accuracy estimates [33].
This review has several potential limitations, including publication bias and insufficient
information from study reports. Although we found no clear evidence of significant publica-
tion bias, studies showing poor test performance might be less (or more) likely to be published.
Furthermore, given the high variability in the study results and the fact that most studies used
diagnostic cut-offs that differed from the international recommendations, our results must be
interpreted with caution. Finally, to ensure that the results can be generalized, we included
studies with both diabetic and non-diabetic participants. We expect that antidiabetic medica-
tions have the same effect on the HbA1c, FPG and 2h-PG levels; however, we cannot rule out
the possibility of some differences associated with specific drugs or clinical settings.
Conclusion
The three recommended tests for the diagnosis of type 2 diabetes show sufficient accuracy for
their use in clinical settings, although the overall accuracy for the diagnosis of retinopathy was
slightly higher for HbA1c and 2h-PG than for FPG. Due to the variability and inconveniences
of the glucose level-based methods, the HbA1c test might be the most appropriate method for
the diagnosis of type 2 diabetes in nonpregnant adults. However, the appropriate use of this
information requires an evaluation of the clinical context, specifically, whether the test will be
used for screening or diagnosis, the availability of the test in underdeveloped countries and the
costs.
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